A contingent from the Alliance for CME went to Washington, D.C., in October to meet with a senior staff member at the United States Senate Committee on Finance. The Alliance initiated the meeting in response to the SFC's report on CME. The result of a two-year investigation into pharmaceutical grants, the report, issued in April, and a subsequent letter to the Accreditation Couincil for CME, expressed concerns about drug industry influence over education and the ACCME's oversight of ...

Register for Complete Access (Valid Email Required)

By registering on MeetingsNet now, you'll not only gain access to Printer-friendly, you'll get exclusive access to a large archive of premium content.

Already registered? here.